From: Meta-analyses of FibroTest diagnostic value in chronic liver disease
Observed AUROC | |
---|---|
Adjacent stages | |
F1 vs. F0 (1,788) | 0.62 0.59–0.65 |
HCV (1,327) | 0.64 0.60–0.68 |
HBV (180) | 0.64 0.56–0.72 |
ALD (85) | 0.47 0.32–0.60 |
NAFLD (196) | 0.53 0.45–0.61 |
F2 vs. F1(n = 2,055) | 0.66 0.63–0.68 |
HCV (1,654) | 0.66 0.63–0.69 |
HBV (155) | 0.63 0.53–0.71 |
ALD (117) | 0.65 0.53–0.74 |
NAFLD (129) | 0.69 0.57–0.78 |
F3 vs. F2 (n = 1,059) | 0.67 0.64–0.70 |
HCV (829) | 0.66 0.62–0.69 |
HBV (99) | 0.78 0.67–0.86 |
ALD (73) | 0.66 0.50–0.77 |
NAFLD (58) | 0.69 0.52–0.80 |
F4 vs F3 (817) | 0.69 0.65–0.72 |
HCV (573) | 0.66 0.61–0.70 |
HBV (81)* | 0.54 0.40–0.65 |
ALD (127)* | 0.82 0.69–0.90 |
NAFLD (36) | 0.71 0.45–0.86 |